{"id":185796,"name":"CANCER LEADERSHIP COUNCIL","slug":"cancer-leadership-council","state":"MD","country":"United States of America","description":"","totalSpending":0,"filings":32,"yearlySpending":[{"year":2018,"income":0},{"year":2019,"income":0},{"year":2020,"income":0},{"year":2021,"income":0},{"year":2022,"income":0},{"year":2023,"income":0},{"year":2024,"income":0},{"year":2025,"income":0}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MED","display":"Medical/Disease Research/Clinical Labs"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"DIS","display":"Disaster Planning/Emergencies"}],"firms":["TURNER & GOSS LLP"],"lobbyists":["ELIZABETH GOSS"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Centers For Disease Control & Prevention (CDC)","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["HR 5247/S 204, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017","S. 204/P.L. 115-176, Right to Try Act of 2017","HR 6826, CLINICAL Treatment Act","Letter responding to Senator Lamar Alexander's request for ideas to reduce health care expenditures","Submit comments to Congress on proposals to strengthen Medicare Part D protections related to beneficiary cost-sharing"]}